- Home
- NVCT vs NVX Comparison
NVCT vs NVX Comparison
Compare NVCT & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCT | NVX |
|---|---|---|
| Founded | 2020 | 2012 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.0M | 224.7M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCT | NVX |
|---|---|---|
| Price | $7.64 | $1.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.33 | N/A |
| AVG Volume (30 Days) | 87.9K | ★ 1.1M |
| Earning Date | 11-04-2025 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,931,433.00 |
| Revenue This Year | N/A | $165.90 |
| Revenue Next Year | N/A | $1,344.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.03 | $0.81 |
| 52 Week High | $11.52 | $3.86 |
Technical Indicators
Market Signals| Indicator | NVCT | NVX |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 40.02 |
| Support Level | $7.57 | $1.00 |
| Resistance Level | $7.91 | $1.13 |
| Average True Range (ATR) | 0.38 | 0.06 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 33.76 | 20.63 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.